Dutasteride Powder

Dutasteride Powder – High-Purity API for Pharmaceutical Manufacturing and Hair Loss Treatment Solutions

Xi'an Le-Nutra Ingredients Inc. supplies pharmaceutical-grade Dutasteride Powder with a guaranteed minimum purity of ≥98% (HPLC), manufactured in a 60,000㎡ GMP-compliant production facility with 3,000 tons annual capacity. Our product features a white crystalline appearance, molecular formula C₂₇H₃₀F₆N₂O₂, and molecular weight 528.53. This dual-type 5α-reductase inhibitor meets USP/EP pharmacopoeia standards with heavy metals ≤20 ppm, loss on drying ≤0.5%, and complete compliance with ICH Q3C residual solvent requirements. With 14+ years of active pharmaceutical ingredient experience, we ensure batch-to-batch consistency, comprehensive COA/TDS/MSDS documentation, and 98% on-time delivery supported by strategic safety stock management.

Understanding Dutasteride as a Dual 5α-Reductase Inhibitor

Dutasteride functions as a potent dual inhibitor targeting both type 1 and type 2 5α-reductase enzymes. These enzymes catalyze the conversion of testosterone to dihydrotestosterone (DHT), a critical hormone implicated in benign prostatic hyperplasia and androgenetic alopecia.

By blocking this biochemical conversion pathway, dutasteride achieves superior DHT suppression compared to single-type inhibitors. Clinical research demonstrates that it reduces serum DHT levels by over 90%, making it highly effective in managing prostate enlargement symptoms. This dual mechanism addresses both peripheral and central androgen metabolism pathways.

For pharmaceutical manufacturers developing BPH medications or prescription hair loss treatments, dutasteride provides robust therapeutic outcomes with minimal dosage requirements. Its high potency translates to cost-effective formulation strategies and improved patient compliance.

Technical Specifications and Quality Parameters

We test thoroughly in our quality control laboratory with high-performance HPLC systems and spectroscopic analysis. All production lots are extensively screened for heavy metals, moisture content, and impurity profiling. Full analytical documentation including HPLC chromatograms is provided for full traceability.

Primary Pharmaceutical Applications

Dutasteride has a number of high-value applications in pharmaceutical development fields. It is an active pharmaceutical ingredient for the treatment of benign prostatic hyperplasia which treats urinary symptoms produced by prostate enlargement. Clinical evidence suggests it considerably reduces the incidence of acute urinary retention and the requirement for surgery.

In dermatological applications,dutasteride shows excellent efficiency in the treatment of androgenetic alopecia. It blocks scalp DHT more effectively than single-enzyme inhibitors, to assist in the restoration of hair follicles and stimulate new hair growth. Pharmaceutical companies are creating prescription hair loss formulations that benefit from its enhanced pharmacological profile.

Dutasteride is also being used as a molecular tool by research institutions to study processes of the androgen pathway. Its selectivity for 5α-reductase enzymes is very beneficial for the modelling of prostate diseases and research of hormone metabolism. The pharmaceutical intermediate uses are also in the area of combination therapy development, especially in dutasteride-tamsulosin formulations designed to attack various BPH routes simultaneously.

Manufacturing Capabilities and Production Advantages

Our production facility with an area of 60000㎡ has six multi-functional production lines equipped with the latest extraction and purifying equipment. This infrastructure enables us to keep the quality of Dutasteride Powder manufacturing to the standard specifications, and also to meet the customised purity specifications. It has a production capability of 3,000 tonnes per year, enough for large-scale pharmaceutical production projects.

Strict GMP processes are followed at each step in the production cycle from verification of raw materials to final packaging. Our skilled R&D team is consistently optimising the synthesis techniques to improve the yield efficiency and minimise the development of impurities. The product is stable when stored in a temperature controlled storage system with long-term storage at -20°C and short term handling at 2-8°C in a light shielded environment.

Factory direct supply removes the middle men markups and assures competitive pricing structures for bulk orders. We have strategic inventory reserves greater than 30 days to support just-in-time delivery requirements. Packaging Flexible packaging options include 1kg, 5kg, 10kg for R&D applications and 25kg fibre drums with double layer food grade polyethylene lining for commercial production.

Global Compliance and Quality Assurance

Our quality management system is in accordance with worldwide pharmaceutical standards such as GMP, ISO and FDA. Each batch of production is tested at multiple stages to confirm identity, quantify purity and screen for contamination. Third party laboratory validation and full certificates of analysis are backed.

The product is pharmaceutical-grade API with stringent criteria of pharmacopoeia. Our residual solvent testing is in accordance with ICH Q3C requirements, therefore safe for human therapeutic use. Heavy metal content is consistently below 20 ppm by rigorous selection of raw materials and purifying methods .

We supply the necessary regulatory documents to ease your product registrations in different areas. With expertise serving customers in North America, Europe and Southeast Asia, we know the regional differences in compliance. The technical dossiers comprise stability data, impurity profiles and analytical method validation studies.

Customization and OEM/ODM Services

Our wide range of customisation options are more than standard requirements. We provide combination therapy formulation help, specification modifications for special purposes and private label services. Our R&D team collaborates with clients to optimise dose forms, boost bioavailability and develop bespoke formulations.

We advise companies developing new delivery systems on technical aspects of incorporating dutasteride into soft gelatin capsules, oral solutions and transdermal formulations. We have pilot scale equipment that enables us to test formulations before full commercial manufacturing. The proper shelf life is determined by stability studies under various storage circumstances.

Packaging can be customised with your own drum labels, bag sizes and nitrogen flushing for added stability. We can support some documentation needs like multi-language labels and region-specific regulatory statements. Our variable MOQ regulations help support research stage projects and commercial volume manufacturing.

FAQ

Q: What makes dutasteride more effective than single-type 5α-reductase inhibitors?

A: Dutasteride inhibits both isoforms of 5α-reductase (type 1 and type 2) allowing for more complete suppression of DHT This dual method decreases serum DHT by more than 90% compared to around 70% with single type inhibitors. This increased enzyme coverage results in better clinical outcomes for both the management of BPH symptoms and the therapy of hair loss.

Q: How should the product be stored by the pharmaceutical maker to preserve stability?

A: Storage: For long term storage keep at -20°C in light shielded containers with little air contact. Short term handling during formulation Keep refrigerated at 2-8°C. The product, when stored properly, has a shelf life of 24 to 36 months. Avoid humidity above 60% RH since the crystalline structure can absorb moisture and influence dissolving properties.

Q: Are there combination formulations of dutasteride with alpha-blockers?

A: Yes, combination therapy has a big commercial opportunity. Dutasteride is useful in combination with tamsulosin and other alpha blockers, by targeting complimentary pathways of BPH. Our technical team provides compatibility data and formulation recommendations to help develop fixed-dose combination solutions to improve patient convenience and therapeutic efficacy.

Q: What documents do you submit for regulatory filing?

A: We supply the full analytical certificates such as COA, TDS, MSDS and the whole HPLC chromatograms. Further documentation, including details of the production process, impurity qualification reports, stability study data and analytical technique validation protocols, is available upon request. Our paperwork bundle meets DMF filing and regional product registration standards.

Q: How long does it take to get big pharmaceutical orders?

A: In stock material ships within 3-5 business days of order confirmation. Production time is 10-12 days for custom purity specifications or bulk quantities over normal inventory. We communicate transparently during production and give shipping tracking for all overseas deliveries. Our 98% on-time delivery rate is proof of our dedication to supply chain reliability.

Contact Us for Pharmaceutical-Grade Dutasteride Supply

Request Dutasteride Powder samples, technical specifications, or pricing information by contacting our team at enquiry@lenutra.com